- Home
- IMNN vs AWX Comparison
IMNN vs AWX Comparison
Compare IMNN & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- AWX
- Stock Information
- Founded
- IMNN 1982
- AWX 1998
- Country
- IMNN United States
- AWX United States
- Employees
- IMNN N/A
- AWX N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- AWX Environmental Services
- Sector
- IMNN Health Care
- AWX Utilities
- Exchange
- IMNN Nasdaq
- AWX Nasdaq
- Market Cap
- IMNN 12.1M
- AWX 9.7M
- IPO Year
- IMNN 1985
- AWX 1998
- Fundamental
- Price
- IMNN $5.75
- AWX $2.44
- Analyst Decision
- IMNN Buy
- AWX
- Analyst Count
- IMNN 2
- AWX 0
- Target Price
- IMNN $182.61
- AWX N/A
- AVG Volume (30 Days)
- IMNN 55.7K
- AWX 2.6K
- Earning Date
- IMNN 11-06-2025
- AWX 11-07-2025
- Dividend Yield
- IMNN N/A
- AWX N/A
- EPS Growth
- IMNN N/A
- AWX 306.94
- EPS
- IMNN N/A
- AWX 0.03
- Revenue
- IMNN N/A
- AWX $78,200,000.00
- Revenue This Year
- IMNN N/A
- AWX N/A
- Revenue Next Year
- IMNN N/A
- AWX N/A
- P/E Ratio
- IMNN N/A
- AWX $80.62
- Revenue Growth
- IMNN N/A
- AWX N/A
- 52 Week Low
- IMNN $4.83
- AWX $2.10
- 52 Week High
- IMNN $41.22
- AWX $3.99
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- AWX 44.18
- Support Level
- IMNN $5.53
- AWX $2.40
- Resistance Level
- IMNN $5.89
- AWX $2.49
- Average True Range (ATR)
- IMNN 0.32
- AWX 0.04
- MACD
- IMNN 0.07
- AWX -0.00
- Stochastic Oscillator
- IMNN 23.81
- AWX 20.00
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.